<DOC>
	<DOC>NCT00097799</DOC>
	<brief_summary>This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.</brief_summary>
	<brief_title>Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<verification_date>October 2013</verification_date>
</DOC>